Difficulty: Medium
Average Score: 82%
Practice
The major limitation to the use of benzodiazepines in anxiety is:
Correct answer
C
Rationale
In the context of pharmacology, the major limitation to the use of benzodiazepines in anxiety is dependence, which is why option C is correct. Benzodiazepines have a high potential for tolerance and dependence, leading to withdrawal symptoms upon discontinuation. This can result in patients requiring higher doses over time to achieve the same therapeutic effect, increasing the risk of addiction.
Option A, no antidote being available if overdose toxicity occurs, is not the major limitation of benzodiazepines in anxiety. In fact, there is an antidote called flumazenil that can be used to reverse benzodiazepine toxicity.
Option B, cardiovascular depression being common, is not a typical limitation of benzodiazepines. While they can cause some central nervous system depression, leading to effects like drowsiness, they are not known for causing significant cardiovascular depression.
Option D, increased risk of respiratory depression, is more commonly associated with opioid medications rather than benzodiazepines. Benzodiazepines can cause some respiratory depression, especially in cases of overdose or when used in combination with other central nervous system depressants, but it is not their major limitation in the treatment of anxiety.
Understanding the limitations and potential risks associated with benzodiazepines is crucial for healthcare providers to make informed decisions when prescribing these medications for anxiety. Education on the risks of dependence and the importance of monitoring patients for signs of tolerance and withdrawal is essential for safe and effective pharmacological treatment.
Option A, no antidote being available if overdose toxicity occurs, is not the major limitation of benzodiazepines in anxiety. In fact, there is an antidote called flumazenil that can be used to reverse benzodiazepine toxicity.
Option B, cardiovascular depression being common, is not a typical limitation of benzodiazepines. While they can cause some central nervous system depression, leading to effects like drowsiness, they are not known for causing significant cardiovascular depression.
Option D, increased risk of respiratory depression, is more commonly associated with opioid medications rather than benzodiazepines. Benzodiazepines can cause some respiratory depression, especially in cases of overdose or when used in combination with other central nervous system depressants, but it is not their major limitation in the treatment of anxiety.
Understanding the limitations and potential risks associated with benzodiazepines is crucial for healthcare providers to make informed decisions when prescribing these medications for anxiety. Education on the risks of dependence and the importance of monitoring patients for signs of tolerance and withdrawal is essential for safe and effective pharmacological treatment.